Default company panoramic image
38a34f41 f710 466c a0d5 37b43c08cf59

Target Pharma UK Ltd

Target Pharma UK Ltd is an emerging company in the rapidly expanding generic pharmaceutical market. Based in the Stanmore region outside of London, Target h...

  • Stage Product In Development
  • Industry Biotechnology
  • Location London, GB-ENG, United Kingdom
  • Currency GBP
  • Founded August 2011
  • Employees 2
  • Website targetph.com

Company Summary

Target Pharma UK Ltd is an emerging company in the rapidly expanding generic pharmaceutical market. Based in the Stanmore region outside of London, Target has identified a large number of branded drug products approaching patent expiry in the time periods of 2012 to 2016. This includes over 11M product prescriptions in 2012 alone. The UK generic drug market is currently valued at £3.5 billion and expected to grow to over £5.1 billion by 2016.

Team

  • Default avatar
    Ajit Srimal
    Mr

    CEO Mr Srimal is a leading industry executive professional with an extensive background in the pharmaceutical industry. He has led LPC Pharmaceuticals to new heights in growth and profitability. The company is examining exit opportunities for the owners and Mr Srimal has started the process for the exciting new project, Target Pharma UK Ltd.

  • Default avatar
    Dipak Shah
    Mr

    COO Mr Shah is an accomplished pharmaceutical executive with operational responsibilities including regulatory, quality assurance and control, manufacturing, license and corporate development and extensive project management experience. He has identified the projected pharmaceutical license targets for Target's market entry as has worked in developing the Company's intended partners in quality compliance, manufacturing, and distribution.

  • Default avatar
    Robert J Sexauer
    Mr

    Non-executive Director
    Mr. Sexauer has been involved in the medical technology industry since 1979 and has served in expanding executive corporate positions. In 2006, he formed InterMark Associates Ltd., a London based consulting organization focused on the regenerative bio pharmaceutical medicine industry. Among projects undertaken included a turn around as CEO of Telomolecular Corporation, a CA based Nanotechnology Company that resulted in a